Advertisement

Topics

Beam Therapeutics Company Profile

08:06 EDT 23rd July 2018 | BioPortfolio

Beam Therapeutics is developing precision genetic medicines through base editing. Founded by leading scientists in CRISPR gene editing, Beam is pursuing therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Headquartered in Cambridge, Massachusetts, the company is backed by F-Prime Capital Partners and ARCH Venture Partners, two of the world’s leading biotech venture capital firms. For additional information, visit www.BeamTx.com.


News Articles [879 Associated News Articles listed on BioPortfolio]

Beam Therapeutics launched to develop Harvard base editing technology

(Harvard University) Harvard University has granted a worldwide license to Beam Therapeutics, Inc., to develop and commercialize a suite of revolutionary DNA base editing technologies for the treatmen...

Beam Therapeutics sublicenses Editas' gene editing technologies

Recently founded Beam Therapeutics Inc. sublicensed exclusive rights to intellectual property related to various genome editing technologies Editas Medicine Inc. had gained through previous deals with...

With $87 Million in Hand, Beam Therapeutics Launches to Fight Disease with CRISPR Base Editing Te...

Beam Therapeutics, a new precision genetic medicines company, launched this morning with $87 million in a Series A funding round backed by F-Prime Capital Partners and ARCH Venture Partners.

Havard University grants license to Beam Therapeutics to develop new base editing technology

Harvard University has granted a worldwide license to Beam Therapeutics, Inc., to develop and commercialize a suite of revolutionary DNA base editing technologies for the treatment of human disease.

Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M

The founders of CRISPR-Cas9 startup Editas Medicine have gotten a jump on the next version of CRISPR gene editing. Scientists from Harvard University, Massachusetts General Hospital, and the Broad Ins...

Beam launches, raises up to $87mm via Series A

Beam Therapeutics has launched with up to $87mm in Series A funding led by F-Prime Capital Partners and Arch Venture Partners.

Beam receives gene editing technology licence from Harvard

US start-up Beam Therapeutics has secured a worldwide licence from Harvard University to develop and commercialise a DNA base editing...Read More... The post Beam receives gene editing technology lice...

Beam receives gene-editing technology licence from Harvard

US start-up Beam Therapeutics has secured a worldwide licence from Harvard University to develop and commercialise a DNA base editing...Read More... The post Beam receives gene-editing technology lice...

PubMed Articles [912 Associated PubMed Articles listed on BioPortfolio]

Extended focus depth for Gaussian beam using binary phase diffractive optical elements.

A novel technique to improve the focus depth of a Gaussian beam is presented in this paper. The improvement is based on two-step beam shaping using a cascade of binary phase diffractive optical elemen...

High-quality partially coherent Bessel beam array generation.

We propose a protocol for generating high-quality, partially coherent (quasi-)Bessel beam arrays with controllable beam order and spatial distributions. Our protocol involves, apart from beam intensit...

Interplay of Kerr and Raman beam cleaning with a multimode microstructure fiber.

We experimentally study the competition between Kerr beam self-cleaning and Raman beam cleanup in a multimode air-silica microstructure optical fiber. Kerr beam self-cleaning of the pump is observed f...

Orbital angular momentum transition of light using a cylindrical vector beam.

We demonstrate that using a single cylindrical vector (CV) beam in two-mode fibers, the orbital angular momentum of light can be switched among -1, 0, and 1. The input CV beam can be a conventional ra...

Beam quality improvement by controlling thermal lens spherical aberration in an end-pumped Nd:YVOlaser.

We present for the first time, to the best of our knowledge, the influence of spherical aberration on the beam quality of a single-stage laser amplifier. We set up an amplifier with a special structur...

Clinical Trials [602 Associated Clinical Trials listed on BioPortfolio]

Proton Beam Radiation Therapy for Early Stage Adenocarcinoma of the Prostate

The primary purpose of this study is to determine if high doses of radiation using proton beam can be given safely with low and acceptable side effects. This study will also gather data t...

Proton Beam Therapy for Chondrosarcoma

The goal of this clinical research study is to learn if proton beam therapy, with or without photon beam radiation therapy, is effective in the treatment of skull base chondrosarcoma. The ...

Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer or Hepatic Metastases

The main purpose of this study is to determine if high doses of radiation using proton beam can be given safely with low and acceptable side effects. We will also gather information to de...

Proton Beam Therapy for Chordoma Patients

Primary Objectives: To establish the efficacy of proton beam therapy with or without photon beam radiation therapy for skull base chordoma. Secondary Objectives: 1. To det...

Proton Beam Radiotherapy for Medulloblastoma and Pineoblastoma

There are two types of external radiation treatments (proton beam and photon beam). As part of the participant's treatment, they will receive radiation to the entire central nervous syste...

Companies [1276 Associated Companies listed on BioPortfolio]

E-BEAM Services

E-BEAM Services, Inc. is a leading supplier of contract electron beam processing services, with more than 450kW of installed accelerator capacity -- enough to process nearly one billion pounds of mate...

Beam Therapeutics

Beam Therapeutics is developing precision genetic medicines through base editing. Founded by leading scientists in CRISPR gene editing, Beam is pursuing therapies for serious dise...

Suitable Technologies, Inc.

The Suitable Technologies Beam product family revolutionizes remote interaction by combining user-controlled device mobility with professional video conferencing for an immersive ...

Beam Global Spirits & Wine, Inc.

Inspiring conversations around the world, Beam Global Spirits & Wine, Inc. is building brands people want to talk about. Consumers from all corners of the globe call for our brands, including Jim Beam...

Beam Global Spirits & Wine

Inspiring conversations around the world, Beam Global Spirits & Wine, Inc. is building brands people want to talk about. Consumers from all corners of the globe call for our brands, including Jim Beam...

More Information about "Beam Therapeutics" on BioPortfolio

We have published hundreds of Beam Therapeutics news stories on BioPortfolio along with dozens of Beam Therapeutics Clinical Trials and PubMed Articles about Beam Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Beam Therapeutics Companies in our database. You can also find out about relevant Beam Therapeutics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record